Prevention and treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage
Cerebral vasospasm after aneurysmal subarachnoid hemorrhage (aSAH) remains a significant cause of morbidity and mortality. Post-hemorrhage cerebral vasospasm (PHCV) occurs through a complex pathophysiology, and numerous pharmacologic agents, including vasodilators, anti-inflammatories, an...
Saved in:
Main Authors: | Kyle McGrath, Grace Hey, Ghaidaa Ebrahim, Noah Gilberstadt, David Mahan, Brandon Lucke-Wold |
---|---|
Format: | Article |
Language: | English |
Published: |
Academia.edu Journals
2023-12-01
|
Series: | Academia Biology |
Online Access: | https://www.academia.edu/111154260/Prevention_and_treatment_of_cerebral_vasospasm_following_aneurysmal_subarachnoid_hemorrhage |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnosis and treatment of cerebral vasospasm after subarachnoid hemorrhage
by: Youssef Fardos, et al.
Published: (2023-12-01) -
Impact of Clazosentan on Vasospasm Reduction and Functional Recovery after Aneurysmal Subarachnoid Hemorrhage
by: Sosho KAJIWARA, et al.
Published: (2025-01-01) -
Relationship between age and delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage requiring invasive mechanical ventilation: a secondary analysis
by: Qing-qing Wu, et al.
Published: (2025-02-01) -
Neurocranial Pharmacodialysis Device for subarachnoid hemorrhage treatment—a perspective
by: Nandor Ludvig
Published: (2024-02-01) -
Management of eight cases of subarachnoid hemorrhage using transpulmonary thermodilution during clazosentan therapy
by: Hiroto Iyota, et al.
Published: (2025-03-01)